siRNA, Anti-FBXL13, 2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT63618WQ-2MOE)

The product SIRGT63618WQ-2MOE is a type of small interfering RNA (siRNA) that targets FBXL13 gene and regulates the expression of gene. The siRNA interferes with the expression of FBXL13 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001111038.1
Alternative Names DRC6; Fbl13
Related Diseases Spinocerebellar Ataxia
Purification HPLC
Target Gene
Gene ID 222235
Uniprot ID Q8NEE6
Sub Cat Target Species Modification Scale  
SIRGT61618WQ-RB FBXL13 Human Ribo-modified Inquiry
SIRGT62618WQ-BB FBXL13 Human Backbone-modified Inquiry

Related Products